Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
作者： Stephen G. Swisher , Wayne Hofstetter , Tsung T. Wu , Arlene M. Correa , Jaffer A. Ajani
DOI: 10.1097/01.SLA.0000161983.82345.85
关键词:
摘要: … , the clinical stages were II, III, or IVA (celiac lymph node … with surgery alone while more advanced tumors were usually … 0, P0 to distinguish them from patients with carcinoma in situ …
elsevier.com
utsystem.edu
lww.com参考文章(20)
W.H. Steup, P. De Leyn, G. Deneffe, D. Van Raemdonck, W. Coosemans, T. Lerut, Tumors of the esophagogastric junction: long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of ptnm classification☆☆☆★★★♢ The Journal of Thoracic and Cardiovascular Surgery. ,vol. 111, pp. 85- 95 ,(1996) , 10.1016/S0022-5223(96)70404-X
A A Forastiere, M B Orringer, C Perez-Tamayo, S G Urba, M Zahurak, Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. Journal of Clinical Oncology. ,vol. 11, pp. 1118- 1123 ,(1993) , 10.1200/JCO.1993.11.6.1118
Yoshio Ishibashi, Tomoe Matsumoto, Mikio Niwa, Yutaka Suzuki, Nobuo Omura, Nobuyoshi Hanyu, Koji Nakada, Katsuhiko Yanaga, Kyosuke Yamada, Kiyoshi Ohkawa, Makio Kawakami, Mitsuyoshi Urashima, CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer. ,vol. 101, pp. 1994- 2000 ,(2004) , 10.1002/CNCR.20593
Arnulf H. Hölscher, Elfriede Bollschweiler, Rudolf Bumm, Holger Bartels, Heinz Höfler, J. Rüdiger Siewert, Prognostic factors of resected adenocarcinoma of the esophagus Surgery. ,vol. 118, pp. 845- 855 ,(1995) , 10.1016/S0039-6060(05)80275-2
Robert J. Korst, Valerie W. Rusch, Ennapadam Venkatraman, Manjit S. Bains, Michael E. Burt, Robert J. Downey, Robert J. Ginsberg, Proposed Revision Of The Staging Classification For Esophageal Cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 115, pp. 660- 670 ,(1998) , 10.1016/S0022-5223(98)70332-0
J. M. Müller, H. Erasmi, M. Stelzner, U. Zieren, H. Pichlmaier, Surgical therapy of oesophageal carcinoma. British Journal of Surgery. ,vol. 77, pp. 845- 857 ,(2005) , 10.1002/BJS.1800770804
Björn L.D.M. Brücher, Wolfgang Weber, Markus Bauer, Ullrich Fink, Norbert Avril, Hubert J. Stein, Martin Werner, Frank Zimmerman, J. Rüdiger Siewert, Markus Schwaiger, Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography Annals of Surgery. ,vol. 233, pp. 300- 309 ,(2001) , 10.1097/00000658-200103000-00002
Stephen G. Swisher, Jeremy Erasmus, Mary Maish, Arlene M. Correa, Homer Macapinlac, Jaffer A. Ajani, James D. Cox, Ritsuko R. Komaki, David Hong, Hoon K. Lee, Joe B. Putnam, David C. Rice, W. Roy Smythe, Linh Thai, Ara A. Vaporciyan, Garrett L. Walsh, Tsung-Teh Wu, Jack A. Roth, 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. ,vol. 101, pp. 1776- 1785 ,(2004) , 10.1002/CNCR.20585
Stephen G Swisher, Jaffer A Ajani, Ritsuko Komaki, Jonathan C Nesbitt, Arlene M Correa, James D Cox, Sandeep Lahoti, Faye Martin, Joe B Putnam, W.Roy Smythe, Ara A Vaporciyan, Garrett L Walsh, Jack A Roth, Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 57, pp. 120- 127 ,(2003) , 10.1016/S0360-3016(03)00522-4
Thomas W. Rice, Eugene H. Blackstone, Lisa A. Rybicki, David J. Adelstein, Sudish C. Murthy, Malcolm M. DeCamp, John R. Goldblum, Refining esophageal cancer staging The Journal of Thoracic and Cardiovascular Surgery. ,vol. 125, pp. 1103- 1113 ,(2003) , 10.1067/MTC.2003.170